Renaissance Technologies
CALC icon

Renaissance Technologies’s CalciMedica CALC Stock Holding History

Renaissance Technologies’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Sell
97,300
-30,775
-24% -$21.8K ﹤0.01% 2977
2026
Q1 		$69.2K Buy
128,075
+39,775
+45% +$80.7K ﹤0.01% 3075
2025
Q4 		$582K Buy
88,300
+18,300
+26% +$71.4K ﹤0.01% 2512
2025
Q3 		$215K Buy
70,000
+34,000
+94% +$97.8K ﹤0.01% 3112
2025
Q2 		$57.6K Buy
36,000
+584
+2% +$1K ﹤0.01% 3374
2025
Q1 		$67.6K Sell
35,416
-7,784
-18% -$19.4K ﹤0.01% 3249
2024
Q4 		$153K Buy
+43,200
New +$151K ﹤0.01% 3224
2023
Q1 		– Sell
-11,143
Closed -$78K – 3998
2022
Q4 		$78K Sell
11,143
-3,178
-22% -$35.6K ﹤0.01% 3692
2022
Q3 		$189K Buy
14,321
+10,600
+285% +$150K ﹤0.01% 3402
2022
Q2 		$57K Buy
3,721
+1,197
+47% +$16.3K ﹤0.01% 3976
2022
Q1 		$43K Buy
2,524
+1,738
+221% +$33.1K ﹤0.01% 3928
2021
Q4 		$20K Buy
+786
New +$30.5K ﹤0.01% 3838

Other funds holding CALC

LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies's CALC Position: Q2 2026 in Review

Renaissance Technologies reduced its CalciMedica (CALC) stake by 24% in Q2 2026, selling an estimated $21.8K and leaving 97,300 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2977.

Renaissance Technologies first reported a position in CALC in Q4 2021 and has held it in 12 quarters since. The position peaked at $582K in Q4 2025. 19 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Renaissance Technologies held 97,300 shares of CalciMedica worth $100K as of Q2 2026.
  • Renaissance Technologies sold 30,775 CalciMedica shares in Q2 2026, an estimated $21.8K.
  • CalciMedica made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2977 holding.
  • Renaissance Technologies first reported a position in CalciMedica in Q4 2021 and has held it in 12 quarters since.
  • Renaissance Technologies's CalciMedica position peaked at $582K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.